Form 4: Organon CIO Stahler Reports PSU Vesting, Share Transactions

Organon & Co.'s Chief Information Officer, Rachel A. Stahler, reported the vesting of performance share units and related share transactions, increasing her beneficial ownership.

Summary

• Rachel A. Stahler, Chief Information Officer of Organon & Co., reported transactions related to her beneficial ownership of common stock.
• On February 27, 2026, 23,178 shares of common stock vested from Performance Share Units (PSUs) granted on August 11, 2023, following certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
• An additional 6,540 shares of common stock were released to cover dividend equivalents earned on the vested PSUs.
• Stahler disposed of 8,475 shares at $7.17 per share and 2,240 shares at $7.23 per share to cover tax withholding obligations.
• Her beneficial ownership after these transactions is 98,310.292 shares of Organon & Co. common stock.
• The reported beneficial ownership also includes the addition of 2,076.678 shares of common stock acquired from dividend equivalents net of withholding tax not previously required to be reported.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting the successful vesting of executive performance-based compensation, which implies the achievement of company goals.

Positives

• The vesting of Performance Share Units indicates that performance goals set by Organon's Board of Directors were attained, reflecting positively on company performance.
• The net increase in beneficial ownership by a key executive (Rachel A. Stahler) aligns management interests with shareholders.

Negatives

• Disposition of 10,715 shares (8,475 + 2,240) to cover tax withholding reduces the executive's direct shareholding, though this is a standard practice for equity compensation.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine Form 4 filings, such as this one detailing executive equity compensation vesting and tax-related sales, are common across industries. They reflect standard practices for incentivizing and compensating senior leadership, aligning their interests with long-term company performance. This filing does not provide specific industry-wide insights beyond standard executive compensation practices.

Comparison to Industry Standards

• The use of Performance Share Units (PSUs) as a component of executive compensation is a common practice in the pharmaceutical and biotechnology sectors, similar to companies like Pfizer or Merck, which also tie executive bonuses to performance metrics.
• The disposition of shares to cover tax obligations upon vesting is a standard and expected procedure for equity awards across all industries, consistent with practices at major corporations globally.

Corporate Governance

Related Party Transactions

• The vesting of Performance Share Units (PSUs) and dividend equivalents are transactions between the executive and Organon & Co. as part of the company's 2021 Incentive Stock Plan.
• The disposition of shares for tax withholding purposes represents a transaction with the company to fulfill tax obligations arising from the equity compensation.

Stakeholder Impact

• Shareholders: The vesting of PSUs indicates that performance targets were met, which could be viewed positively. The net increase in insider ownership (after tax sales) aligns executive and shareholder interests.
• Employees: This filing reflects the company's executive compensation structure and the successful achievement of performance incentives, which can influence broader employee morale and understanding of compensation practices.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events, specifically the vesting of performance share units and subsequent tax-related share dispositions. While it indicates that performance goals were met, which is a positive operational sign, it does not provide new material information about the company's financial performance or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing confirms standard corporate governance and compensation practices without altering the fundamental investment thesis.

Keywords

Organon & Co., OGN, Rachel A. Stahler, Chief Information Officer, Form 4, Insider Trading, Performance Share Units, PSUs, Stock Vesting, Equity Compensation, Beneficial Ownership